INTRODUCTION
It is hard to conceive that chromosomal number alterations should be an exception at the end of all cell divisions (including gametogenesis) needed to produce a newborn individual (1) . When such alterations occur early in development, they produce the so-called aneuploid syndromes, which encompass all human genetic disorders caused by † The authors wish it to be known that, in their opinion, the first three authors should be regarded as joint First Authors. * To whom correspondence should be addressed. increased (normally gain of a single chromosome or trisomy) or decreased number of chromosomes (monosomy) (2) . These syndromes account for approximately one-third of all spontaneous abortions, normally in the first trimester, and have as well profound consequences on the survivors. Apart from the more obvious physical deformities, they are also a leading cause of mental disability, altogether representing a very incapacitating problem for the affected individuals and their families. Despite increased practice of provoked abortions following antenatal diagnosis, it is important to understand these disorders because they will never disappear, and perhaps-to at least some extent-the functional consequences might be treatable. However, our current knowledge is poor at the molecular level, which is in part due to lack of adequate tools such as cell lines or animal models. The existing patients do not represent a good option because of routine inaccessibility to affected tissues (e.g. brain) and the circumstance that the abnormalities may not be present in terminally differentiated cells. Moreover, when the aneuploidy arose very early during development, the individuals may bear a variable mosaic of euploid (normal number of chromosomes) and aneuploid cells that can make conclusions difficult. Recently, embryonic stem cell (ESC) lines were produced from aneuploid blastocysts discarded after pre-implantation genetic screening (3) . The achievement is relevant but the number of cell lines is yet scarce, some represent a mosaic (euploid/ aneuploid), and the procedure is not fully free of ethical concerns. An interesting alternative that bypasses these and other issues is the generation of induced pluripotent stem cells (iPSCs) from somatic cells of surviving individuals (e.g. skin) or fetal tissues (e.g. amniocytes). This procedure allows the creation of ESC-like cell lines by epigenetic reprogramming of a variety of donor cell types (4 -6) . Notably, the differentiation of patient-specific iPSCs into specific cell lineages has already proven valuable to study several human diseases 'in a Petri dish' (7 -9) . Here, we aimed to create a panel of iPSCs from aneuploid syndromes that could be used for in vitro disease modeling.
RESULTS
Amniocytes from a Turner syndrome (hereafter referred to as TS) (10) pregnancy were collected as part of the routine antenatal diagnosis in a local hospital. The use of this cell type as a source for reprogramming (11) is interesting because it allows the generation of iPSCs from fetuses that otherwise may undergo spontaneous abortion, as it happens in most TS cases. Skin fibroblasts from patients with trisomy 8 (Warkany syndrome 2) (12), trisomy 9 (13), trisomy 13 (Patau syndrome) (14) , partial trisomy 11;22 (Emanuel syndrome or derivative 22 syndrome) (15) , hereafter termed TRI8, TRI9, TRI13 and Der (22) , plus two patients with TS, were obtained from the Coriell cell repositories. Der (22) is a condition with origin in a balanced chromosome 11;22 translocation in one of the parents, who is however asymptomatic (15) . Further details of the primary cell types and selected phase contrast photographs are displayed in Table 1 and Figure 1A ; confirmatory karyotype analysis was performed before the reprogramming (Table 1 and Fig. 1A ). Of note, fibroblasts from TRI9 carried a mosaic phenotype rather than complete aneuploidy (Table 1 ). All cell types were transduced with retroviral or lentiviral vectors that produce SOX2, KLF4, OCT4 and c-MYC, using protocols reported previously (16, 17) . The reprogramming efficiency varied, ranging from moderately high to low or very low (Table 1) . Around days 25-30 post-infection, a number of colonies with ESC-like morphology were picked from all experiments, including TRI13 that produced only one. After initial expansion, optimal clones belonging to each group were selected, for which we repeated the karyotyping to discard acquisition of additional chromosome alterations (18 Table S1 ), rather than contamination with existing cell types in our laboratory whose reprogramming could have induced karyotype changes. Next, we did alkaline phosphatase (AP) ( Fig. 2A ) and immunofluorescence staining for ESC surface markers (TRA-1-60 and TRA-1-81, SSEA-3 and SSEA-4) and the transcription factor NANOG, all of which showed a pattern comparable to human ESCs ( Fig. 2A) . Human female iPSCs are known to display variable levels of X chromosome inactivation (19) that can be visualized by immunofluorescence staining for the repressive histone modification mark H3K27me3 (histone 3 lysine 27 trimethylation). We observed a strong dot indicative of X chromosome inactivation in the nuclei of control female iPSCs, but this was absent in TS iPSCs (Fig. 2B ). Quantitative reverse transcriptase -polymerase chain reaction (qPCR) demonstrated expression of selected endogenous pluripotent transcription factors (SOX2, OCT4, NANOG and REX1) at the level of ESCs in iPSCs (two different passages were tested) derived from all four syndromes ( Fig. 3A and B) . Flow cytometry analysis of SSEA-4 and qPCR for OCT4 (the two performed in parallel) further confirmed stability of the ESC-like phenotype in TS iPSCs at three different passages (Fig. 3C) . The same was observed at the morphology level in iPSCs from the other aneuploid syndromes (data not shown). Moreover, DNA microarrays of three TS iPSC clones corresponding to the same patient showed a global gene expression pattern similar to ESCs and euploid iPSCs and very different from donor cells (Fig. 4A ). We detected transcriptomic changes between TS iPSCs and the other ESCs/iPSCs, but these variations did not follow a pattern and in fact all pluripotent cell lines clustered together (Fig. 4A ). Indeed, differentially expressed (DE) genes with fold change greater than 1.5 in TS iPSCs compared with H9 ESCs and selected control iPSCs were not abundant ( Fig. 4B) . Out of these, 77 were located in autosomes (both up-regulated and down-regulated) and only two in X chromosome (down-regulated) (Fig. 4C) . The latter two genes, ASMTL (N-acetylserotonin O-methyltransferase-like protein; P ¼ 0.000068) and PPP2R3B (serine/threonine-protein phosphatase 2A regulatory subunit B; P ¼ 0.003966), are pseudoautosomal genes (20) that have active homologous sequences in X and Y chromosomes and escape X chromosome inactivation. To demonstrate specificity, we performed qPCR of iPSCs derived from all three TS patients and included additional control iPSCs. This analysis was performed separately for clones generated using retroviruses (TS1) or lentiviruses (TS2 and 3). Euploid iPSCs generated from the same cell source (amniocytes or fibroblasts) using the same reprogramming method (retroviruses or lentiviruses) were included for a faithful comparison. The analysis showed downregulation of ASMTL and PPP2R3B in TS iPSCs compared with the controls (Fig. 4D) , confirming that the alteration is real and not caused by variations in the epigenome of specific clones due to abnormal reprogramming. The basal expression of both genes was, nevertheless, high in all iPSC clones tested (Ct value approximately [21] [22] , suggesting a role in normal development. ASMTL function is not known but is likely related to methyltransferase activity (21) , whereas PPP2R3B is involved in cell cycle control (22, 23) . Next, we verified 
Immunofluorescence microscopy for H3K27me3 shows signal concentration on the inactivated X chromosome in normal female iPSCs from UMCs (two clones), but not in two TS iPSC clones. Scale bar indicates 25 mm. We used the following passages: UMC-iPS-C1 P18, UMC-iPS-C6 P33, TS2-iPS-C7 P12 and TS2-iPS-C12 P12.
genomic integration of the exogenous factors by semiquantitative PCR (Fig. 5A ). Their expression (two different passages were tested) was significantly silenced (studied by qPCR), as expected for cells that have reached a pluripotent state (Fig. 5B ). Bisulfite sequencing also showed extensive CpG demethylation of the OCT4 and NANOG proximal promoters compared with donor cells (Fig. 5C ). Therefore, we have successfully reprogrammed somatic cells from aneuploid syndromes to iPSCs, and the resulting cell lines can be expanded without losing their ESC-like characteristics. We evaluated pluripotency by producing embryoid bodies (EBs) (iPSCs at two different passages were tested) ( Fig. 6A and B) and growing teratomas in immunocompromised mice (Fig. 7) . Lineages corresponding to the three germ layers were detected for all tested iPSC clones without obvious bias between the four syndromes or when compared with ESCs (included as a control for the EBs) ( Figs 6B and 7) . The teratomas contained rather complex structures such as respiratory epithelium, goblet cells and others (Fig. 7) . We then chose TS iPSCs as a representative model for more detailed tissue-specific differentiation study; see Table 1 for a summary. First, we compared the up-regulation of placental markers in EBs from TS iPSCs of the three donors and in EBs from a panel of euploid iPSCs (Fig. 6C) . As mentioned earlier, we divided the analysis into two groups, based on the donor cell type and the reprogramming method. Urbach and Benvenisty (24) had previously suggested that insufficient placentation is a reason for early lethality in TS embryos. The authors employed an interesting but suboptimal model-H9 ESCs that had spontaneously lost one X chromosome-and noticed that the derived EBs display lower expression of the placenta-related genes FAM46A, colony-stimulating factor 2 receptor alpha (CSF2RA), PAPPA2, VGLL1, GATA3 and STS than their euploid counterparts. We tested those genes plus chorionic gonadotropin subunit alpha and placenta growth factor because they produce relevant factors involved in placenta formation (25, 26) (Fig. 6C and Supplementary Material, Fig. S1A and B) . Of note, out of all eight tested candidates, only the pseudoautosomal gene CSF2RA (27) showed statistically significant difference in both the retroviral and the lentiviral groups (Fig. 6C) . GATA3, which is located in chromosome 10, was changed only in the retroviral group (Supplementary Material, Fig. S1A and B) . This could simply indicate a domino effect or be a consequence of the reprogramming method, but we cannot discard that the X chromosome imbalance somehow alters GATA3 expression in certain genetic backgrounds. The degree of silencing of the transgenes varied between EBs from different iPSC * * P , 0.01. For the retroviral (RV) group, we used the following clones and passages: TS1-iPS-C1 P28 and P32, TS1-iPS-C2 P28 and P32, TS1-iPS-C5 P29 and P33, A20-iPS-C14 P26 and P27, A20-iPS-C16 P24 and P26, UMC-iPS-C1 P18 and P22 and UMC-iPS-C6 P33 and P37; for the lentiviral (LV) group, we used: TS2-iPS-C7 P20 and P21, TS2-iPS-C11 P20 and P21, TS3-iPS-C7 P16 and P22, TS3-iPS-C12 P16 and P22, AP-iPS-C1 P19 and P20, AP-iPS-C3 P20 and P21 and NOR-iPS-C3 P16 and P17.
clones (without following a pattern), but was notable in all cases compared with the controls (Supplementary Material, Fig. S1C -F) . Next, we performed directed differentiation of TS iPSCs into neural-like cells, hepatocyte-like cells and cardiomyocyte (CM)-like cells. Multiple iPSC clones corresponding to the three TS donor cell types were used for this purpose; see Table 1 for a description. Differentiation into neural-like cells was successful in all tested cell lines based on expression of PAX6 and SOX1 [neural progenitor cell (NPC) markers], S100 (astrocyte marker), MAP2, bIII-tubulin and Synapsin (the three are neuronal markers) detected by immunofluorescence (Fig. 8A) and flow cytometry analysis for FORSE-1 (NPC marker) (Fig. 8B ). NPCs were also produced from two TRI8 iPSCs and showed no obvious alteration in generation efficiency either (Fig. 8B) . Likewise, TS iPSCs differentiated into hepatocyte-like cells (Fig. 8C ) and beating clusters (produced through EB formation) containing CMs (Fig. 9A) , as assessed by immunofluorescence staining for AFP (a-fetoprotein), A1AT (a1-antitrypsin), cTnT (cardiac troponin T) and a-actinin. These CMs contained cells displaying spontaneous action potentials characteristic of the three main heart morphologies (atrial, nodal and ventricular) (7) (Fig. 9B ), which were similar to CMs derived from euploid iPSCs (Fig. 9C) or ESCs (data not shown). Action potential duration was slightly elevated in TS CMs compared with control iPSCs, but the difference was not statistically significant (Fig. 9C) . Taken together, these results suggest that the ability of iPSCs from aneuploidy syndromes to produce tissue-specific lineages is intact.
DISCUSSION
The high frequency of early lethality in aneuploid syndromes is not well understood, and there is a need for new models that help to understand it. The selective time distribution-mostly in the first trimester-suggests the involvement of rather general mechanisms (3). TRI13 is among the group of aneuploid syndromes that more frequently survives to term, whereas TRI8, Der (22) and, in particular, TS often result in miscarriage. In the latter condition, it is remarkable that ,1% of all affected embryos progress to birth (10). Several not excluding possibilities can be envisaged to explain this circumstance: first, the pluripotent state of TS cells at very (B) qPCR analysis for pluripotent genes and lineage-specific markers corresponding to the three germ layers at day 8 after attaching the EBs for another 8 days on gelatin-coated dishes; H9 ESCs were the control. Error bars correspond to SD of the three replicates used for the qPCR. We used the following passages: for early passage TS1-iPS-C2 P16, TRI8-iPS-C12 P12, TRI13-iPS-C1 P11 and Der(22)-iPS-C4 P12; for later passage TS1-iPS-C2 P29, TRI8-iPS-C12 P25, TRI13-iPS-C1 P24 and Der(22)-iPS-C4 P31; H9 ESCs P59. (C) Box plot analysis of gene expression for the indicated placental-related genes measured by qPCR in EB samples from control iPSCs and TS iPSCs. The following control and TS iPSC clones were used for the retroviral group (one EB formation assay for each): TS1-iPS-C1 P34 and P36, TS1-iPS-C5 P15 and P33, UC-C0406-iPS-C4 P29, P30 and P31, UC-C0406-iPS-C1 P29 and P30, A20-iPS-C14 P26 and P27, A20-iPS-C16 P24 and P26, UMC-iPS-C1 P17 and P19, IMR90-iPS-C2 P27 and P29 and IMR90-iPS-C8 P33 and P34. The following control and TS iPSC clones were used for the lentiviral group (one EB formation assay for each): TS2-iPS-C7 P10 and P11, TS2-iPS-C11 P10 and P11, TS3-iPS-C7 P11 and P12, TS3-iPS-C12 P11 and P12, AP-iPS-C1 P20, AP-iPS-C3 P20 and P21 and NOR-iPS-C3 P16 and P17.
* P , 0.05; NS, not significant. early stages of development (e.g. in the morula) may be unstable, and therefore, differentiation is triggered too quickly and/or randomly; secondly, TS embryonic cells suffer a differentiation blockade, and certain lineages and/or structures cannot be formed properly and this causes fetal death; thirdly, a more general problem such as inadequate placentation and/or unbalanced cell proliferation alters coordinated fetal growth, ultimately causing abortion. All three possibilities would as well explain that if the TS embryos go through a certain barrier, then they would still tend to accumulate related defects resulting in malformations, but the newborns would be in general viable. If the first situation were true, then one would expect that the reprogramming of TS somatic cells to iPSCs is impossible, as when the pluripotent state is reached, these cells would automatically degenerate or transform into something that does not resemble ESCs.
However, our aneuploidy iPSC lines (including TS) are not only ESC-like but also phenotypically stable. This is also in agreement with the observation that reprogramming can be achieved by cell fusion (producing aneuploidy) (28) , and the not unusual circumstance that iPSC clones generated from euploid donors may be aneuploid but still behave like ESCs in most assays (18) . In the second scenario, aneuploid blastocysts would either not faithfully differentiate into one or more of the three germ layers (ectoderm, endoderm or mesoderm) or bear specific defects in certain cell lineages (e.g. cardiac mesoderm). Against an obvious defect in differentiation, we have observed that all tested iPSCs from the four aneuploid syndromes formed rather complex teratomas. TS iPSCs could as well produce specific lineages upon directed differentiation in vitro. These differentiated cell types seemed morphologically and functionally (at least in the case of CMs) indistinguishable from those produced from ESCs or euploid iPSCs, though we cannot discard subtle defects with relevant implications in vivo (perhaps only after birth). If the latter were true, our iPSCs would still be an excellent tool for such study. For example, long QT syndrome and other arrhythmias are more frequent in females with TS than in normal females, but the underlying reason is unclear (29) . Our TS CMs produced from a large panel of TS iPSCs did not display a statistically significant longer QT interval compared with control cells, but it remains possible that drug administration would magnify existing defects and allow mechanistic study (7) . It is also interesting to notice that TS females have specific cognitive problems in visuospatial, mathematical and memory areas, despite that their overall intelligence is close to normal (10) . These defects are not surprising if we consider that the X chromosome contains the highest ratio of genes related to cognition compared with other chromosomes (30, 31) . Potentially, the analysis of NPCs and neurons from TS iPSCs would shed light into this issue and might as well help understand cognitive differences between unaffected men and women. The same can be said for the other aneuploid syndromes presented here, as they are also cause of mental retardation. Nevertheless, even though the existence of subtle lineage-specific differentiation defects causing organ collapse and abortion in TS fetuses is formally possible, our findings that CSF2RA and PPP2R3B expression is reduced in TS iPSCs support the existence of a different more general type of problem. CSF2RA is a pseudoautosomal gene encoding a subunit of the receptor for granulocytemacrophage colony-stimulating factor, which is essential for placenta development. It seems thus plausible to envisage that a reduction in CFS2RA during early development, which to some extent can be mimicked in vitro by EB formation, could produce inadequate placentation in TS fetuses. This is in agreement with data by Urbach and Benvenisty (24) and with previous autopsy reports, describing that in general spontaneously aborted TS embryos cannot form noticeable organs (32) . It is also tempting to speculate that haploinsufficiency of CSF2RA might participate in the altered immune responses of TS individuals (33) . In contrast, PPP2R3B is a pseudoautosomal gene whose product is a subunit of protein phosphatase 2A. The latter acts as a negative regulator of cell proliferation and is important for the correct exit of mitosis during early embryonic cell division (22, 23) . Theoretically, PPP2R3B reduction might alter cell proliferation during early embryonic development and indirectly also tissue-specific differentiation due to improper synchronization. We did not observe noticeable increased proliferation in TS iPSCs compared with the controls (data not shown), but it is possible that the mitotic defect is more relevant in vivo and/or becomes apparent when TS blastocysts differentiate. Hence, taken together, our panel of TS iPSCs provides not only a plausible model explaining in part why TS fetuses die but also a valuable tool to test other ideas. In the future, it will be interesting to contrast these concepts by comparing these iPSCs with ESCs produced from aneuploid blastocysts (3).
MATERIALS AND METHODS

Cell culture and iPSC generation
All fibroblasts were maintained in Dulbecco's modified Eagle's medium (DMEM) (Invitrogen, Carlsbad, CA) + 10% fetal bovine serum (FBS) (Hyclone, Logan, UT) and amniocytes in AmnioGrow Plus (Cytogen, Sinn, Germany). Cells were transduced with a cocktail of pMX-based retroviruses encoding human SOX2, KLF4, OCT4 and c-MYC (Addgene, Cambridge, MA) as reported before (16) or using a polycistronic lentiviral vector encoding the same factors (OCT4, KLF4, SOX2 and c-MYC) linked by P2A, T2A and E2A sequences in this order (34) . Picked iPSCs and human ESCs [H9 (XX) and H1 (XY) ESCs purchased from WISC Bank (Madison, WI)] were routinely maintained on feeders (mitotically inactivated-murine embryonic fibroblasts) in human ESC medium [DMEM/F12 (Invitrogen) plus 20% KnockOut Serum Replacement (KSR, Invitrogen), penicillin/streptomycin, 1 mM glutamine, 0.1 mM Percentage of CMs with the three characteristic morphologies in a control iPSC clone generated from urine samples and TS iPSCs. TS2-iPS-C7 P19, TS2-iPS-C11 P19, TS3-iPS-C7 P20 and TS3-iPS-C12 P20 were differentiated into CMs; data from all of them were pooled (also in C and D). The shape of the respective action potentials is included near each cell type. (C) Maximum diastolic potential, plus action potential duration at 90% (APD90) and 50% (APD50) repolarization in the three cell types.
non-essential amino acids, 0.1 mM beta-mercaptoethanol and 8 ng/ml basic fibroblast growth factor (bFGF) (Shenzhen Symmix Industry, Shenzhen, China)] or on Matrigel (BD Biosciences, Bedford, MA) in mTeSR1 (Stemcell Technologies, Vancouver, BC, Canada). iPSCs from fetal fibroblasts (IMR90 cell line; clones IMR90-iPS-C2 and C8; XX) and skin fibroblasts of a patient with Wilson's disease (clones WD-iPS-C1, C2 and C3; XY) (35) , periosteum membrane (clones Peri-iPS-C1 and C2; XY) (16) , umbilical cord mesenchymal cells (UMCs; clones UMC-iPS-C1 and C6; XX) and placenta [amniotic mesenchymal cells (AMCs) and chorionic mesenchymal cells (CMCs); clones AMC-iPS-C2 and C28, CMC-iPS-C1 and C28; XX] (36) and epithelial cells present in urine (clones UC-C0406-iPS-C1 and C4; XX) (37) were derived using retroviruses and have been described before. Clone NF1-4-iPS-C11 was generated from skin fibroblasts of a healthy middle age individual (XY); clones A20-iPS-C14 and C16 were produced from amniocytes of a normal fetus (XY) using retroviruses. These three clones have not been described before, but in all cases, qPCR analysis for ESC genes and the transgenes, immunofluorescence microscopy, DNA methylation analysis and teratomas were comparable to other control iPSCs (data not shown). Consent form for these donor cell types is available upon request; this and other procedures followed guidelines approved by the appropriate Ethics Committee. iPSCs from fibroblasts of a patient with a1-antitrypsin deficiency (clones AP-iPS-C1 and C3; XX) and a healthy individual (clone NOR-iPS-C3; XY) were generated using the above-described polycistronic lentiviral vector by Drs Zychlinski, Hofmann and Schambach. These iPSC clones were comparable to other control iPSCs as well and will be described in full elsewhere.
iPSC characterization AP staining, transgene integration and bisulfate sequencing were performed following standard procedure. Primers used for these and other procedures can be found in Supplementary Material, Table S2A . For karyotype analysis, we used a 10 cm plate with cells growing in logarithmic phase. They were fed with fresh medium the night before adding colcemid, which was maintained 2 h at 378C in the incubator. Cells were then trypsinized, treated with hypotonic solution (0.075 M KCl) for 20 min and fixed with methanol: acetic acid (3:1). Metaphases were spread on microscope slides, and chromosomes were classified according to the International System for Human Cytogenic Nomenclature using the standard G banding technique. At least, 20 metaphases were counted per cell line, and the final karyotype was stated if it was present in more than 85% of them. For short tandem repeat analysis, we purchased the service of Kingmed (Guangzhou, China). Genomic DNA was extracted using the DNeasy Tissue kit (Qiagen, Valencia, CA), and total RNA was extracted using Trizol reagent (Invitrogen). qPCR was performed using a Thermal Cycler DiceTM Real Time System (ABI7300; ABI, Foster City, CA) and SYBR Green Premix EX TaqTM (Takara, Shiga, Japan); beta actin was used for normalization and all items were measured in triplicate. Flow cytometry was performed using a BD FACSAria machine (BD Biosciences). DNA microarrays were performed using the Affymetrix HuGene 1.0 ST array platform, and data were analyzed using robust multi-array analysis algorithm with the Partek genomics suite 6.5 (Partek, St. Louis, MO). Hierarchical clustering was done with the R statistics package (http://www.r-p roject.org/). GEO accession number for the DNA microarrays of TS1 amniocytes, Fib-1 and Fib-3 fibroblasts, periosteum, TS and CMC iPSCs is GSE32527; others included in this manuscript have been reported elsewhere. For teratomas, iPSCs were injected into the right hind leg of immunocompromised NOD-SCID mice. Tumors were excised after 8 weeks, fixed, embedded in paraffin, sectioned and stained with hematoxylin/eosin. EBs were produced by two methods. In method 1 (as in Fig. 6A and B) , iPSCs/ESCs were detached with Dispase (Invitrogen), plating the suspended cells onto low adherence dishes for 8 days in human ESC medium without bFGF. EBs were then plated onto gelatin-coated dishes in the same medium for another 8 days before RNA was extracted. In method 2 (as in Fig. 6C and Supplementary Material, Fig. S1 ), the EBs were maintained in suspension for 18 days, and RNA was collected on days 2, 6, 10 and 18; the day showing the highest expression value for each individual gene was selected for the analysis.
Lineage-specific differentiation
Neural-like, hepatocyte-like and CM-like differentiation was performed as described (38) (39) (40) . N2, B27, RPMI 1640 and hepatoZYME-SPF were purchased from Invitrogen; Heparin from Sigma (St. Louis, MO); EGF, Activin A and oncostatin M from R&D Systems (Minneapolis, MN) ; BMP2, FGF4, HGF and KGF from PeproTech (Rocky Hill, NJ) and dexamethasone from Enzo Life Sciences (Farmingdale, NY).
Immunofluorescence microscopy
For immunofluorescence, cells were fixed in 4% paraformaldehyde for 30 min, washed, blocked and permeabilized in blocking solution (phosphate-buffered saline containing 3% bovine serum albumin and 0.2% Triton X-100) for 30 min. Then they were incubated with primary antibodies in blocking solution at 48C overnight, washed twice and incubated with the corresponding secondary antibodies for 1 h at room temperature. Cells were washed twice and stained with DAPI (Sigma) for 5 min and then observed and photographed using a LEICA DMI6000B microscope (Leica Microsystems GmbH, Buffalo Grove, IL). Antibodies used in this study are summarized in Supplementary Material, Table S2B .
Electrophysiological measurements
Electrophysiological characterization of CMs derived from normal iPSCs and TS iPSCs was done at day 20 of differentiation using standard whole-cell patch-clamp at 378C (HEKA Instruments Inc., Southboro, MA) (41) . Patch-clamp pipettes were prepared from 1.5 mm thin-walled borosilicate glass tubes using a Sutter micropipette puller P-97 and had typical resistances of 3 -5 MV when filled with an internal solution containing (mM): 110 K-aspartate, 20 KCl, 1 MgCl 2 , 0.1 Na-GTP, 5 Mg-ATP, 5 Na 2 -phosphocreatine, 5 EGTA, 10 HEPES and pH adjusted to 7.3 with KOH. The external Tyrode's bath solution consisted of (mM): 140 NaCl, 5 KCl, 1 MgCl 2 , 0.4 KH 2 PO 4 , 1.8 CaCl 2 , 10 glucose, 5 HEPES and pH adjusted to 7.4 with NaOH. Spontaneous electrical activity was measured, whereas the iPSC-CMs were left passive without current input. Twenty consecutive action potentials from spontaneously firing iPSC-CMs were recorded per cell to ensure stable waveforms for analysis. Data were corrected for the liquid junction potentials of +15.9 mV.
Statistical analysis
Analysis was performed with independent samples t-test using SPSS 13.0 software. In the box plots, the value 1 is given to the median among TS samples of each group.
